XML 67 R37.htm IDEA: XBRL DOCUMENT v3.20.1
Summary of significant accounting policies (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
customer
Dec. 31, 2018
USD ($)
customer
Concentration Risk [Line Items]    
Allowance for accounts receivable $ 0 $ 0
Accounts receivable $ 444 $ 578
Customer Concentration Risk | Revenue | Allergan    
Concentration Risk [Line Items]    
Number of customers | customer 1 1
Concentration risk percentage 100.00% 75.00%
Customer Concentration Risk | Accounts Receivable | Allergan    
Concentration Risk [Line Items]    
Accounts receivable $ 400 $ 600